Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-04-23

Clinical Trial Update: Study of Safety and Efficacy of PF-04991532 in Subjects With Type 2 Diabetes [Phase 2]

View source ↗

Summary

Pfizer completed a Phase 2 trial evaluating the safety and efficacy of PF-04991532 in adults with type 2 diabetes; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PF-04991532 (PF-04991532)

Snippet

Sponsor: Pfizer | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED | Results posted: 2013-04-23